Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes

Naomi Weintrob*, Shlomit Shalitin, Moshe Phillip

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

CSII is a feasible, safe and well-accepted mode of therapy for many children with type 1 diabetes. For a significant number of patients and parents, it serves as a much easier means of coping with the huge daily burden of diabetes. Therefore, we believe that both CSII and MDI should be made available to the diabetic team and the patients to better tailor therapy, improved satisfaction and decrease the fear of hypoglycemia.

Original languageEnglish
Pages (from-to)271-275
Number of pages5
JournalIsrael Medical Association Journal
Volume6
Issue number5
StatePublished - May 2004

Keywords

  • Adolescents
  • Children
  • Continuous subcutaneous insulin infusion
  • Diabetes
  • Multiple daily insulin injections
  • Pumps

Fingerprint

Dive into the research topics of 'Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes'. Together they form a unique fingerprint.

Cite this